Universal Cells
Focus: Universal Cells is a public biotechnology company specializing in non-immunogenic cell therapies, headquartered in Seattle, with a focus on respiratory, cardiovascular, infectious disease, rare disease, and oncology applications.
Profile data last refreshed 10h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
4-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at Universal Cells?
AI assessmentHigh-risk career move due to recent major layoffs and apparent operational shutdown, despite innovative platform; suitable only for risk-tolerant candidates seeking early-stage cell therapy exposure or those with specific domain expertise in non-immunogenic engineering.
Why Work Here
- Access to cutting-edge cell therapy platform targeting multiple high-value therapeutic areas with unmet medical needs.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Help build intelligence for Universal Cells
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.